BACKGROUND: Current evidence on the relationship between human papillomavirus (HPV) DNA detection and menstrual cycle has been inconsistent. METHODS: We included 21 nonoral contraceptive pill (non-OCP) users who self-collected vaginal samples twice per week for 16 weeks. We explored whether variable detection of HPV DNA exhibited cyclic or other structured temporal patterns. We also evaluated relationships between serial HPV prevalence, sexual behavior, and suspected bacterial vaginosis (BV) as defined by Nugent Gram stain score ≥7. RESULTS: During follow-up, any-type HPV prevalence varied between 61.1% and 85.0%. Although not statistically significant, we observed a maximum autocorrelation in serial HPV prevalence lagging 14 days (correlation coefficient [ρ], -0.24). Any-type HPV detection had a periodic behavior, generally repeating every 28.0 days (bootstrapped interquartile range, 22.4-28.0) and peaking around the ovulation time (adjusted odds ratio, 1.96; 95% confidence interval [CI], 1.06-3.62) as compared to menstruation. We also showed that an increase in any-type HPV prevalence preceded the beginning of a menstrual cycle by 9-12 days. There was no evidence of relationships between HPV prevalence and sexual activity or Nugent score. CONCLUSIONS: Serially detected any-type HPV DNA showed a periodic behavior and was likely to peak in the periovulatory phase among non-OCP users.
BACKGROUND: Current evidence on the relationship between human papillomavirus (HPV) DNA detection and menstrual cycle has been inconsistent. METHODS: We included 21 nonoral contraceptive pill (non-OCP) users who self-collected vaginal samples twice per week for 16 weeks. We explored whether variable detection of HPV DNA exhibited cyclic or other structured temporal patterns. We also evaluated relationships between serial HPV prevalence, sexual behavior, and suspected bacterial vaginosis (BV) as defined by Nugent Gram stain score ≥7. RESULTS: During follow-up, any-type HPV prevalence varied between 61.1% and 85.0%. Although not statistically significant, we observed a maximum autocorrelation in serial HPV prevalence lagging 14 days (correlation coefficient [ρ], -0.24). Any-type HPV detection had a periodic behavior, generally repeating every 28.0 days (bootstrapped interquartile range, 22.4-28.0) and peaking around the ovulation time (adjusted odds ratio, 1.96; 95% confidence interval [CI], 1.06-3.62) as compared to menstruation. We also showed that an increase in any-type HPV prevalence preceded the beginning of a menstrual cycle by 9-12 days. There was no evidence of relationships between HPV prevalence and sexual activity or Nugent score. CONCLUSIONS: Serially detected any-type HPV DNA showed a periodic behavior and was likely to peak in the periovulatory phase among non-OCP users.
Entities:
Keywords:
Auto-correlation; Bacterial Vaginosis; Human Papillomavirus; Menstrual Cycle; Nugent Score; Periodicity; Spectral Analysis; Time Series Analysis
Authors: J Schwartz; C Spix; G Touloumi; L Bachárová; T Barumamdzadeh; A le Tertre; T Piekarksi; A Ponce de Leon; A Pönkä; G Rossi; M Saez; J P Schouten Journal: J Epidemiol Community Health Date: 1996-04 Impact factor: 3.710
Authors: D Heather Watts; Melissa Fazzari; Melissa Fazarri; Howard Minkoff; Sharon L Hillier; Beverly Sha; Marshall Glesby; Alexandra M Levine; Robert Burk; Joel M Palefsky; Michael Moxley; Linda Ahdieh-Grant; Howard D Strickler Journal: J Infect Dis Date: 2005-02-21 Impact factor: 5.226
Authors: J Brisson; I Bairati; C Morin; M Fortier; C Bouchard; A Christen; P Bernard; M Roy; A Meisels Journal: J Infect Dis Date: 1996-04 Impact factor: 5.226
Authors: Anne F Rositch; Eshan U Patel; Molly R Petersen; Thomas C Quinn; Patti E Gravitt; Aaron A R Tobian Journal: Clin Infect Dis Date: 2021-05-04 Impact factor: 9.079
Authors: Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen Journal: J Gen Virol Date: 2015-12 Impact factor: 3.891
Authors: Su-Hsun Liu; Anne F Rositch; Raphael P Viscidi; Michelle I Silver; Anne E Burke; Patti E Gravitt Journal: J Infect Dis Date: 2013-07-09 Impact factor: 5.226
Authors: Su-Hsun Liu; Derek A T Cummings; Jonathan M Zenilman; Patti E Gravitt; Rebecca M Brotman Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10-15 Impact factor: 4.254
Authors: Diane E Halliwell; Maria Kyrgiou; Anita Mitra; Ilkka Kalliala; Evangelos Paraskevaidis; Georgios Theophilou; Pierre L Martin-Hirsch; Francis L Martin Journal: Sci Rep Date: 2016-12-15 Impact factor: 4.379